Record numbers of children with RSV are now being seen at Yale New Haven Children’s Hospital and Connecticut Children’s. Meanwhile, Pfizer says it will seek FDA approval this year for its RSV vaccine. The drug company says it has enough promising data on its vaccine that it will end enrollment in its study and submit it for approval. We spoke to Dr. Browne about the latest on RSV cases and how soon we will see vaccines.
IMAGE CREDIT: iStock / Getty Images Plus